Sanofi and Lonza have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility. The facility, to be built in Visp, Switzerland, will be established through a joint venture with an initial investment of around CHF 290 million shared equally between Sanofi and Lonza. Jones & Day and Walder Wyss acted as legal counsels to Sanofi in this matter. The Walder Wyss team included Luc Defferrard (Partner / M&A), Michael Isler (Partner / IPIT), Ramona Wyss (Managing Associate /M&A IPIT), Tina Hurni (Associate / Real Estate) and Alexandra Brenner (Associate / Real Estate).